AmGraft single and dual layer amniotic membrane allograft product packaging box

AmGraft™ and AmGraft™ Plus – Single and Dual Layer Amniotic Allograft

TitleRangeDiscount
DEG Promo5 - 9 $129.00
DEG Promo10 + $125.00

AmGraft Amniotic Membrane Allograft — Single and Dual Layer

AmGraft™ amniotic membrane allograft is a human placental-based tissue product processed using Amnion’s proprietary AmnioCleanse™ tissue purification technology. This minimally manipulated amniotic membrane allograft is intended for homologous use, delivering the essential biological structure found in human amnion.

How AmGraft Amniotic Membrane Allograft Works

When placed over the wound site, AmGraft™ serves as a protective biological barrier, conforming naturally to the wound surface. The single and dual layer configurations give clinicians flexibility to match the right thickness to each patient’s needs. AmGraft™ is custom-designed for ease of use and can be easily sutured or gently placed over the surgical site.

Quality & Safety Standards

Every AmGraft™ amniotic membrane allograft is procured and processed according to standards established by the American Association of Tissue Banks (AATB) and the United States Food and Drug Administration (FDA). All tissues are recovered under full informed consent from planned C-section donors. Terminally sterilized using e-beam technology, AmGraft™ is validated for a 5-year shelf life — engineered for long-term reliability in your practice.

Available Sizes

  • 1 × 1 cm
  • 2 × 2 cm
  • 3 × 3 cm
  • 4 × 4 cm
  • 4 × 6 cm
  • 5 × 5 cm
  • 6 × 6 cm
  • 7 × 7 cm
  • 1 × 1 cm – Dual Layer
  • 2 × 2 cm – Dual Layer
  • 3 × 3 cm – Dual Layer
  • 4 × 4 cm – Dual Layer
  • 4 × 6 cm – Dual Layer
  • 5 × 5 cm – Dual Layer
  • 6 × 6 cm – Dual Layer
  • 7 × 7 cm – Dual Layer

Amnion is an ISO 13485-certified and AATB-accredited tissue bank committed to delivering the highest quality allografts direct from our lab. Contact our team to learn more about AmGraft™ for your practice.

Product Standards

AmgraftTM allografts are procured and processed according to standards established by the American Association of Tissue Banks (AATB) and the United State Food and Drug Administration (FDA). All tissues are recovered under full unformed consent of the planned c-section donors (represented by the mothers of the newborn children) The donors have consented to transfer of the the allografts to third parties. A thorough medical exam and social history of the donor is also obtained, including detailed family history.

Tissue Safety

The Donor is Screened for:

  • HBsAg: Hepatitis B Surface Antigen
  • HBcAb: Hepatitis B Core Total Antibody (IgG and IgM)
  • HCVAb: Hepatitis C Antibody
  • HIV 1/2/Ab: Human Immunodeficiency Virus Types 1/2 and O Antibody
  • HCV NAT: Hepatitis C Virus
  • HIV NAT: Human Immunodeficiency Virus
  • HBV NAT: Hepatitis B Virus
  • RPR/STS or Equivalent: Syphilis
  • West Nile Virus (WNV) Assay
  • Along with other clinical and physical evidence, which is relevant and would aid in donor eligibility determination.

All test results are reviewed prior to release of the tissue.

Tissue Safety Image